Literature DB >> 4730841

The pharmacokinetics of unchanged pindolol in patients with impaired renal function.

E E Ohnhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4730841      PMCID： PMC1776349     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis".

Authors:  N S BRICKER; P A MORRIN; S W KIME
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

2.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15
  2 in total
  3 in total

Review 1.  Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

Authors:  D G Shand
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Pharmacokinetics of atenolol in patients with renal impairment.

Authors:  J Sassard; N Pozet; J McAinsh; J Legheand; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

3.  Pharmacokinetics of mepindolol in patients with chronic renal failure.

Authors:  W Krause; D Kampf; H C Fischer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.